看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。- s7 ^# x1 G4 {8 o0 X! e. I
3 Q% w; V" k6 y5 Z4 l9 M; p2 P, D' a9 o5 i( M4 B2 q" K
Currently available feasibility data for possible combination strategies.
5 _- c ]6 B. D. L" [/ b————————————————————————————————
' n/ O9 X+ H' L: H2 nCombination Feasibility according to preliminary data 5 ~( |: T9 z0 A2 k' l1 [3 a
——————————————————————————————————) x5 x1 J* O# v8 L
Bevacizumab + sorafenib Yes, reduced dose @- j+ K* V4 S* B5 _. j/ f
Bevacizumab + sunitinib† No
' K0 V: j# g* M [3 t/ N1 |% m2 O8 L \Bevacizumab + temsirolimus Yes " v) a/ c {9 I! @
Bevacizumab + everolimus Yes 1 O% D( }2 x" e, f# e
Sorafenib + sunitinib ?
9 o; S% T7 L* r' `/ z. h& WSorafenib + temsirolimus Yes, reduced dose / m" n' N% W5 {/ w
Sorafenib + everolimus Yes, reduced dose
0 D" F# Q* }$ l8 _Sunitinib + temsirolimus† No
! X A9 x# ~+ Q3 C: J+ `Sunitinib + everolimus ?
" [* \$ f6 B' I, D) iTemsirolimus + everolimus ? 2 r5 [7 Q7 _ P9 }
————————————————————
+ n0 ~! i. j3 n* l†Led to US FDA warning.( W- k7 V4 U) Q$ p* v
?: As yet unattempted combination.& w& B2 a: }4 a1 F0 O9 {, m
|